Clinical features and prognosis of Miller Fisher syndrome.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 11320188.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors reviewed the clinical features and outcome of Miller Fisher syndrome (MFS) for 50 consecutive patients with MFS including 28 patients who received no immunotherapy. Besides the characteristic clinical triad (ophthalmoplegia, ataxia, and areflexia), pupillary abnormalities, blepharoptosis, and facial palsy are frequent in MFS, whereas sensory loss is unusual despite the presence of profound ataxia. Patients with MFS usually had good recovery and no residual deficits.
Medical subject headings
- Ataxia
- Miller Fisher Syndrome
- Ophthalmoplegia